DEF: Actelis Seeks Shareholder OK for Warrants, Reverse Split
Proxy Statement
Actelis Networks, Inc. is seeking stockholder approval for warrant issuances and a reverse stock split to comply with Nasdaq listing rules and enhance investor appeal.
Summary
- A Special Meeting of stockholders will be held on November 7, 2025, to vote on four key proposals.
- Proposal 1 seeks approval to issue up to 6,704,210 shares of common stock upon the exercise of inducement warrants, which were part of a September 2, 2025 transaction that generated approximately $1.6 million in gross proceeds from existing warrant exercises at a reduced price of $0.37 per share.
- Proposal 2 requests approval for the exercisability of 4,991,878 private placement warrants and the issuance of underlying common stock, stemming from a June 30, 2025 offering that generated approximately $1 million in gross proceeds.
- Proposal 3 aims to amend the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-7 and 1-for-12, at the Board's discretion, primarily to regain compliance with Nasdaq's minimum bid price requirement and attract institutional investors.
- Proposal 4 is for the approval of an adjournment of the Special Meeting, if necessary, to allow for further solicitation of proxies for Proposals 1, 2, and/or 3.
- The Board of Directors unanimously recommends a 'FOR' vote on all four proposals.
- As of the Record Date, September 8, 2025, there were 16,598,509 shares of common stock issued and outstanding.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While the company has secured capital and is taking steps to address Nasdaq compliance, the significant potential dilution from warrant exercises and the inherent uncertainties of a reverse stock split (e.g., whether it will sustainably increase the stock price or improve liquidity) present considerable challenges and risks for existing shareholders. The proposals are largely reactive to existing issues (low stock price, Nasdaq rules) rather than indicative of strong operational performance.
Positives
- The warrant inducement transaction on September 2, 2025, generated approximately $1.6 million in gross proceeds for the company.
- A private placement offering that closed on July 2, 2025, generated approximately $1 million in gross proceeds.
- The proposed reverse stock split is intended to increase the per share price of common stock to regain compliance with Nasdaq's minimum bid price requirement ($1.00 per share).
- The reverse stock split aims to make the common stock more attractive to a broader range of investors, including institutional investors, potentially enhancing liquidity.
- Approval of the warrant exercises could bring in up to an additional $2.51 million from Inducement Warrants and $3.09 million from Private Placement Warrants, providing further capital for operations.
Negatives
- Failure to approve Proposal 1 and 2 would mean the company would not receive potential future proceeds of approximately $2.51 million and $3.09 million, respectively, which could adversely impact the ability to fund operations.
- If Proposal 1 and 2 are not approved, the company would incur substantial additional costs and expenses by being required to seek stockholder approval every 90 days for up to five years.
- Approval of Proposal 1 and 2 will result in significant dilution for existing stockholders upon the issuance of 6,704,210 additional shares from Inducement Warrants and 4,991,878 shares from Private Placement Warrants.
- The sale of these additional shares into the public market could materially and adversely affect the market price of the common stock.
- There is no assurance that the reverse stock split will result in a proportional increase in the market price of common stock, and the total market capitalization could be lower after the split.
- A reduction in the number of outstanding shares due to the reverse stock split may impair the liquidity of the common stock.
- The reverse stock split may lead to some stockholders owning 'odd lots' (less than 100 shares), which can be more difficult to sell and incur higher brokerage commissions.
- The increase in authorized but unissued shares resulting from the reverse stock split could have an anti-takeover effect, potentially limiting opportunities for stockholders to dispose of shares at higher prices in takeover attempts.
Risks
- Risk of delisting from The Nasdaq Capital Market if the company fails to regain compliance with the minimum bid price requirement ($1.00 per share) by November 10, 2025, or during any subsequent compliance period.
- Uncertainty that the reverse stock split, if effected, will sustainably increase the per share price of common stock or maintain Nasdaq compliance.
- Potential for reduced liquidity and a lower total market capitalization of common stock after the reverse stock split.
- Significant dilution of existing stockholders' ownership interests upon the exercise of Inducement Warrants (6,704,210 shares) and Private Placement Warrants (4,991,878 shares).
- Adverse impact on the company's ability to fund operations and achieve strategic goals if stockholder approval for warrant exercises is not obtained, leading to loss of potential proceeds and recurring approval costs.
- The reverse stock split could have an unintended anti-takeover effect by increasing the number of authorized but unissued shares, potentially entrenching current management.
Future Outlook
The company intends to hold a meeting of its stockholders on or prior to 90 days following the closing date of the warrant inducement transaction to obtain stockholder approval. If warrant approvals are not obtained, the company will be required to seek approval every 90 days for up to five years, incurring substantial costs. The Board of Directors reserves the right to elect not to proceed with the reverse stock split if it determines, in its sole discretion, that it is no longer in the best interests of the company and its stockholders. The company expects to continue to be subject to periodic reporting requirements of the Exchange Act and its common stock will continue to be quoted on the Nasdaq Capital Market under the symbol ASNS.
Management Comments
- It is vital that every stockholder votes at the Special Meeting in person or by proxy due to the significance of these proposals to the company and its stockholders.
- The Board of Directors recommends a vote FOR Proposal Nos. 1, 2, 3 and 4.
- The primary reasons for approving and recommending the Reverse Stock Split are to increase the per share price and bid price of our common stock to regain compliance with Nasdaq listing requirements and make the common stock more attractive to certain institutional investors, which would provide for a stronger investor base.
- The Board of Directors is not aware of any attempt to take control of the Company and has not approved the Reverse Stock Split with the intent that it be utilized as a type of anti-takeover device.
Industry Context
Actelis Networks is navigating common challenges faced by smaller public companies, including maintaining compliance with exchange listing requirements (specifically Nasdaq's minimum bid price rule). The company's use of warrant inducement transactions and private placements are standard methods for capital raising and managing capital structure, often involving dilution. The proposed reverse stock split is a typical corporate action employed to address low stock prices and improve market perception, a strategy frequently observed across various industries for companies in similar situations.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Approval of an amendment to the Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-7 to 1-for-12, at the Board's discretion. | To be determined by the Board of Directors, prior to November 7, 2026. | Intended to regain Nasdaq compliance and enhance investor appeal. Will not change the number of authorized shares, thereby increasing the pool of unissued shares available for future issuance without stockholder approval, which could have an anti-takeover effect. |
Stakeholder Impact
- **Shareholders**: Will experience significant dilution upon the exercise of warrants. May benefit from increased stock price and liquidity if the reverse stock split successfully maintains Nasdaq listing and attracts institutional investors, but also face risks of non-proportional price increase, reduced liquidity, and potential anti-takeover effects.
- **Company Operations**: Will receive capital from warrant exercises, which could fund operations. Failure to approve warrant exercises could adversely impact funding and incur substantial recurring costs associated with repeated approval solicitations.
- **Nasdaq**: The company is seeking to comply with Nasdaq listing rules to avoid potential delisting, which is critical for maintaining its public market presence and investor confidence.
Next Steps
- Stockholders are urged to vote on the proposals at the Special Meeting scheduled for November 7, 2025.
- If Proposal 3 is approved, the Board of Directors will determine the exact ratio for the reverse stock split (within the 1-for-7 to 1-for-12 range) and publicly announce it before its effectiveness.
- If stockholder approval for the warrant exercises (Proposals 1 and 2) is not obtained, the company will be required to seek such approval every 90 days until the warrants are no longer outstanding.
- If the reverse stock split is implemented, the company's transfer agent will manage the exchange of stock certificates for registered holders.
Key Dates
| Date | Description |
|---|---|
| December 20, 2023 | Issuance date of 1,271,187 Existing Warrants with an exercise price of $1.18 per share. |
| June 6, 2024 | Issuance date of 999,670 Existing Warrants with an exercise price of $2.00 per share. |
| July 2, 2024 | Issuance date of 1,999,340 Existing Warrants with an exercise price of $1.75 per share. |
| May 12, 2025 | Company notified by Nasdaq Listing Qualifications of non-compliance with minimum bid price requirements. |
| June 30, 2025 | Company entered into a securities purchase agreement for a private placement offering. |
| July 2, 2025 | Private Placement offering closed, issuing Series A-3, Series A-4, and June Placement Agent Warrants. |
| September 2, 2025 | Company entered into an inducement agreement (Inducement Letter) with a warrant holder. |
| September 3, 2025 | Warrant Inducement transaction closed; Company issued New Warrants and September Placement Agent Warrants. |
| September 8, 2025 | Record Date for stockholders entitled to vote at the Special Meeting. |
| September 29, 2025 | Intended mailing date of the Proxy Statement and Proxy Card to stockholders. |
| November 7, 2025 | Date of the Special Meeting of Stockholders at 10:00 a.m. (Eastern Standard Time). |
| November 10, 2025 | Deadline for the company to regain compliance with Nasdaq's minimum bid price requirement. |
| November 7, 2026 | Latest date by which the Board of Directors may effect a reverse stock split if approved by stockholders. |
Recommendation
holdThe company is taking necessary steps to address Nasdaq compliance and has raised some capital through warrant exercises and a private placement. However, the significant potential dilution from warrant exercises and the inherent uncertainties of a reverse stock split (e.g., whether it will sustainably increase the stock price or improve liquidity) suggest a 'Hold' position. Investors should monitor the effectiveness of the reverse stock split and the company's operational performance post-capital raise before making further investment decisions. The risks of delisting and dilution are substantial.
Keywords
Actelis Networks, ASNS, Proxy Statement, Special Meeting, Warrant Inducement, Private Placement, Reverse Stock Split, Nasdaq Listing Rules, Stockholder Approval, Dilution, Capital Raise, Corporate Governance, Shareholder Vote, Equity Financing, Stock Market Compliance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.